Table of Contents 2012-2023 Global Xerostomia (Dry Mouth) Therapeutics Market Research Report by Manufacturers, Regions, Types and Applications 1 Xerostomia (Dry Mouth) Therapeutics Market Overview 1.1 Product Overview and Scope of Xerostomia (Dry Mouth) Therapeutics 1.2 Xerostomia (Dry Mouth) Therapeutics Segment by Type (Product Category) 1.2.1 Xerostomia (Dry Mouth) Therapeutics Segment by Types (Product Category) and Its Subclasses 1.2.2 Global Xerostomia (Dry Mouth) Therapeutics Production Market Share by Type (Product Category) in 2016 1.2.3 Different Subclasses for Salivary Stimulants 1.2.3.1 Subclass 1 1.2.3.2 Subclass 2 1.2.3.3 Subclass 3 1.2.4 Different Subclasses for Salivary Substitutes 1.2.4.1 Subclass 1 1.2.4.2 Subclass 2 1.2.4.3 Subclass 3 1.2.5 Different Subclasses for Dentifrices 1.2.5.1 Subclass 1 1.2.5.2 Subclass 2 1.2.5.3 Subclass 3 1.3 Global Xerostomia (Dry Mouth) Therapeutics Segment by Application 1.3.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Comparison by Applications (2012-2023) 1.3.2 OTC 1.3.3 Prescription 1.4 New Project SWOT Analysis of Xerostomia (Dry Mouth) Therapeutics 1.5 Industry News Analysis of Xerostomia (Dry Mouth) Therapeutics 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics 2.2 Raw Material Analysis of Xerostomia (Dry Mouth) Therapeutics 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Xerostomia (Dry Mouth) Therapeutics 2.4 Other Costs Analysis of Xerostomia (Dry Mouth) Therapeutics 2.5 Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics 2.6 Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics 2.7 Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2017 2.8 Downstream Buyers of Xerostomia (Dry Mouth) Therapeutics 3 Global Xerostomia (Dry Mouth) Therapeutics Manufacturers Profiles/Analysis 3.1 GlaxoSmithKline plc 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.1.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.1.2.1 Salivary Stimulants 3.1.2.2 Salivary Substitutes 3.1.2.3 Dentifrices 3.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 GlaxoSmithKline plc Different Types of Xerostomia (Dry Mouth) Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.2 Church & Dwight Co., Inc. 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.2.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.2.2.1 Salivary Stimulants 3.2.2.2 Salivary Substitutes 3.2.2.3 Dentifrices 3.2.3 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Church & Dwight Co., Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.3 Colgate-Palmolive Company 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.3.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.3.2.1 Salivary Stimulants 3.3.2.2 Salivary Substitutes 3.3.2.3 Dentifrices 3.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Colgate-Palmolive Company Different Types of Xerostomia (Dry Mouth) Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.4 Hikma Pharmaceuticals PLC 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.4.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.4.2.1 Salivary Stimulants 3.4.2.2 Salivary Substitutes 3.4.2.3 Dentifrices 3.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Hikma Pharmaceuticals PLC Different Types of Xerostomia (Dry Mouth) Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.5 Pendopharm 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.5.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.5.2.1 Salivary Stimulants 3.5.2.2 Salivary Substitutes 3.5.2.3 Dentifrices 3.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pendopharm Different Types of Xerostomia (Dry Mouth) Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.6 Sun Pharmaceuticals Industries Ltd. 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.6.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.6.2.1 Salivary Stimulants 3.6.2.2 Salivary Substitutes 3.6.2.3 Dentifrices 3.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sun Pharmaceuticals Industries Ltd. Different Types of Xerostomia (Dry Mouth) Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.7 Lupin Pharmaceuticals, Inc. 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.7.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.7.2.1 Salivary Stimulants 3.7.2.2 Salivary Substitutes 3.7.2.3 Dentifrices 3.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Lupin Pharmaceuticals, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.8 Pfizer, Inc. 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.8.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.8.2.1 Salivary Stimulants 3.8.2.2 Salivary Substitutes 3.8.2.3 Dentifrices 3.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Pfizer, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.9 Parnell Pharmaceuticals, Inc. 3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.9.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.9.2.1 Salivary Stimulants 3.9.2.2 Salivary Substitutes 3.9.2.3 Dentifrices 3.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Parnell Pharmaceuticals, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.10 Acacia Pharma 3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.10.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.10.2.1 Salivary Stimulants 3.10.2.2 Salivary Substitutes 3.10.2.3 Dentifrices 3.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Acacia Pharma Different Types of Xerostomia (Dry Mouth) Therapeutics Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.11 OraCoat 4 Global Xerostomia (Dry Mouth) Therapeutics Market Competition by Manufacturers 4.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production and Share by Manufacturers (2012-2017) 4.1.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity (K Units) and Share (%) by Manufacturers (2012-2017) 4.1.2 Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Share (%) by Manufacturers (2012-2017) 4.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Share (%) by Manufacturers (2012-2017) 4.3 Global Xerostomia (Dry Mouth) Therapeutics Average Price (USD/Unit) by Manufacturers (2012-2017) 4.4 Manufacturers Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution, Sales Area, Product Types 4.5 Xerostomia (Dry Mouth) Therapeutics Market Competitive Situation and Trends 4.5.1 Xerostomia (Dry Mouth) Therapeutics Market Concentration Rate 4.5.2 Xerostomia (Dry Mouth) Therapeutics Market Share (%) of Top 3 and Top 5 Manufacturers 5 Global Xerostomia (Dry Mouth) Therapeutics Production by Regions (2012-2017) 5.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity (K Units) and Market Share (%) by Regions (2012-2017) 5.2 Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Market Share (%) by Regions (2012-2017) 5.3 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share (%) by Regions (2012-2017) 5.4 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.5 North America Xerostomia (Dry Mouth) Therapeutics Production (2012-2017) 5.5.1 North America Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.5.2 North America Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.6 Europe Xerostomia (Dry Mouth) Therapeutics Production (2012-2017) 5.6.1 Europe Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.6.2 Europe Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.7 China Xerostomia (Dry Mouth) Therapeutics Production (2012-2017) 5.7.1 China Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.7.2 China Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.8 Japan Xerostomia (Dry Mouth) Therapeutics Production (2012-2017) 5.8.1 Japan Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.8.2 Japan Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.9 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Production (2012-2017) 5.9.1 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.9.2 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.10 India Xerostomia (Dry Mouth) Therapeutics Production (2012-2017) 5.10.1 India Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) 5.10.2 India Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 6 Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) by Regions (2012-2017) 6.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) by Regions (2012-2017) 6.2 North America Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) by Regions (2012-2017) 6.3 Europe Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) by Regions (2012-2017) 6.4 China Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) by Regions (2012-2017) 6.5 Japan Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) by Regions (2012-2017) 7 Global Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Price Trend by Types 7.1 Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Market Share (%) by Types (2012-2017) 7.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Market Share (%) by Types (2012-2017) 7.3 Global Xerostomia (Dry Mouth) Therapeutics Price (USD/Unit) by Type (2012-2017) 7.4 Global Xerostomia (Dry Mouth) Therapeutics Production Growth (%) by Type (2012-2017) 8 Global Market Analysis by Applications 8.1 Global Consumption (K Units) and Market Share (%) by Applications (2012-2017) 8.2 Global Consumption Growth Rate by Applications (2012-2017) 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Global Xerostomia (Dry Mouth) Therapeutics Market Forecast (2018-2023) 10.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue Forecast (2018-2023) 10.1.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units) and Growth Rate (%) Forecast (2018-2023) 10.1.2 Global Xerostomia (Dry Mouth) TherapeuticsRevenue (Million USD) and Growth Rate (%) Forecast (2018-2023) 10.1.3 Global Xerostomia (Dry Mouth) Therapeutics Price and Trend Forecast (2018-2023) 10.2 Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) Forecast by Regions (2018-2023) 10.2.1 North America Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.2 Europe Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.3 China Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.4 Japan Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.5 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.6 India Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.3 Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast by Regions (2018-2023) 10.3.1 North America Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast (2018-2023) 10.3.2 Europe Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast (2018-2023) 10.3.3 China Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast (2018-2023) 10.3.4 Japan Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast (2018-2023) 10.3.5 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast (2018-2023) 10.3.6 India Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast (2018-2023) 10.4 Global Xerostomia (Dry Mouth) Therapeutics Production, Revenue and Price Forecast by Type (2018-2023) 10.5 Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast by Application (2018-2023) 11 Research Findings and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Disclaimer 12.4 Author List

List of Tables and Figures Figure Global Xerostomia (Dry Mouth) Therapeutics Market Size (Million USD) Status and Outlook 2012-2023 Table Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Revenue (Million USD) Market Split by Product Type Table Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) by Application (2017-2023) Figure Picture of Xerostomia (Dry Mouth) Therapeutics Figure Global Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) by Types in 2016 Figure Global Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) by Subclasses of Salivary Stimulants in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Figure Global Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) by Subclasses of Salivary Substitutes in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Figure Global Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) by Subclasses of Dentifrices in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Table Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Comparison by Applications (2012-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Consumption (USD/Unit) Market Share (%) by Applications in 2016 Figure OTC Examples Figure Prescription Examples Figure New Project SWOT Analysis of Xerostomia (Dry Mouth) Therapeutics Table Industry News List of Xerostomia (Dry Mouth) Therapeutics Figure Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/Unit) Figure Global Raw Material B Price Trend (USD/Unit) Figure Global Raw Material C Price Trend (USD/Unit) Table Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics in 2017 Figure Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics Table Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2017 Table Major Buyers of Xerostomia (Dry Mouth) Therapeutics Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Its Competitors Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (%) (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) (2012-2017) Table Salivary Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in ????OTC and Its Application Share Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Church & Dwight Co., Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (%) (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) (2012-2017) Table Salivary Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Colgate-Palmolive Company Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (%) (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) (2012-2017) Table Salivary Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (%) (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) (2012-2017) Table Salivary Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pendopharm Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (%) (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) (2012-2017) Table Salivary Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (%) (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) (2012-2017) Table Salivary Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Lupin Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (%) (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) (2012-2017) Table Salivary Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in ????OTC and Its Application Share Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pfizer, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (%) (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) (2012-2017) Table Salivary Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in ????OTC and Its Application Share Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Parnell Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (%) (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) (2012-2017) Table Salivary Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in ????OTC and Its Application Share Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Acacia Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017) Figure Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (%) (2012-2017) Figure Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) (2012-2017) Figure Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) (2012-2017) Table Salivary Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in ????OTC and Its Application Share Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Global Xerostomia (Dry Mouth) Therapeutics Capacity (K Units) of Key Manufacturers (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Capacity Market Share (%) of Key Manufacturers (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity Market Share (%) of Key Manufacturers in 2017 Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity Market Share (%) of Key Manufacturers in 2017 Table Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) of Key Manufacturers (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Production Share (%) by Manufacturers (2012-2017) Figure 2016 Xerostomia (Dry Mouth) Therapeutics Production Share (%) by Manufacturers Figure 2016 Xerostomia (Dry Mouth) Therapeutics Production Share (%) by Manufacturers Table Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) by Manufacturers (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Revenue Share (%) by Manufacturers (2012-2017) Table 2016 Global Xerostomia (Dry Mouth) Therapeutics Revenue Share (%) by Manufacturers Table 2016 Global Xerostomia (Dry Mouth) Therapeutics Revenue Share (%) by Manufacturers Table Global Market Xerostomia (Dry Mouth) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2012-2017) Figure Global Market Xerostomia (Dry Mouth) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2017 Table Manufacturers Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution and Sales Area Table Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Category Figure Xerostomia (Dry Mouth) Therapeutics Market Share (%) of Top 3 Manufacturers Figure Xerostomia (Dry Mouth) Therapeutics Market Share (%) of Top 5 Manufacturers Table Global Xerostomia (Dry Mouth) Therapeutics Capacity (K Units) by Regions (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity Market Share (%) by Regions (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity Market Share (%) by Regions (2012-2017) Figure 2016 Global Xerostomia (Dry Mouth) Therapeutics Capacity Market Share (%) by Regions Table Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) by Regions (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) by Regions (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) by Regions (2012-2017) Figure 2016 Global Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) by Regions Table Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) by Regions (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) by Regions (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) by Regions (2012-2017) Figure 2016 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) by Regions Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units) and Growth Rate (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure North America Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) Table North America Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Europe Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure China Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) Table China Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Japan Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) (2012-2017) Table Japan Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Market by Regions (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share (%) by Regions (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share (%) by Regions (2012-2017) Figure 2016 Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share (%) by Regions Figure North America Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure Europe Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure China Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure Japan Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure India Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure South America Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (%) (2012-2017) Figure Middle East Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (%) (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) by Types (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Production Share (%) by Types (2012-2017) Figure Production Market Share (%) of Xerostomia (Dry Mouth) Therapeutics by Types (2012-2017) Figure 2016 Production Market Share (%) of Xerostomia (Dry Mouth) Therapeutics by Types Table Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) by Types (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Revenue Share (%) by Types (2012-2017) Figure Revenue Share (%) of Xerostomia (Dry Mouth) Therapeutics by Types (2012-2017) Figure 2016 Revenue Market Share (%) of Xerostomia (Dry Mouth) Therapeutics by Types Table Global Xerostomia (Dry Mouth) Therapeutics Price (USD/Unit) by Types (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Production Growth (%) by Type (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) by Applications (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share (%) by Applications (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share (%) by Applications (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share (%) by Applications in 2017 Table Global Xerostomia (Dry Mouth) Therapeutics Consumption Growth Rate by Applications (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Growth Rate by Applications (2012-2017) Table Distributors/Traders List Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Global Xerostomia (Dry Mouth) Therapeutics Price and Trend Forecast (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) Forecast by Regions (2018-2023) Figure Global Xerostomia (Dry Mouth) Therapeutics Production Market Share (%) Forecast by Regions (2018-2023) Figure North America Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North America Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure China Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Japan Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast by Regions (2018-2023) Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share (%) Forecast by Regions (2018-2023) Figure North America Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Europe Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South America Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Middle East Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) Forecast by Type (2018-2023) Figure Global Xerostomia (Dry Mouth) Therapeutics Production Forecast by Type (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Forecast by Type (2018-2023) Figure Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (%) Forecast by Type (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Price (USD/Unit) Forecast by Type (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast by Application (2018-2023) Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GlaxoSmithKline plc Church & Dwight Co., Inc. Colgate-Palmolive Company Hikma Pharmaceuticals PLC Pendopharm Sun Pharmaceuticals Industries Ltd. Lupin Pharmaceuticals, Inc. Pfizer, Inc. Parnell Pharmaceuticals, Inc. Acacia Pharma OraCoat